Multiple Sclerosis and Related Disorders

Determining the favorable clinical course in MS 3:23
Determining the favorable clinical course in MS
Nicola De Stefano • 28 Mar 2022
Predicting treatment effect in MS patients: enrichment of certain baseline features in responders 1:34
Predicting treatment effect in MS patients: enrichment of certain baseline features in responders
Jean-Pierre Falet • 22 Mar 2022
Updates in epidemiology data in NMOSD 2:00
Updates in epidemiology data in NMOSD
Michael Levy • 3 Apr 2022
Assessing the peripheral immune compartment of patients with RIS 5:27
Assessing the peripheral immune compartment of patients with RIS
Raphael Schneider • 3 Mar 2022
Deep learning can predict treatment response in patients with progressive MS 8:46
Deep learning can predict treatment response in patients with progressive MS
Jean-Pierre Falet • 22 Mar 2022
Why is personalized medicine important in multiple sclerosis? 2:47
Why is personalized medicine important in multiple sclerosis?
Jean-Pierre Falet • 22 Mar 2022
Prognostic value of circulating NfL for COVID-19 mortality 9:26
Prognostic value of circulating NfL for COVID-19 mortality
Ruturaj Masvekar • 11 Mar 2022
Improving the correlation between serum NfL and CSF NfL 5:32
Improving the correlation between serum NfL and CSF NfL
Ruturaj Masvekar • 11 Mar 2022
Extending the utility of MRI in MS 2:15
Extending the utility of MRI in MS
Nicola De Stefano • 28 Mar 2022
Measuring treatment responses in progressive MS with MRI 3:38
Measuring treatment responses in progressive MS with MRI
Nicola De Stefano • 29 Mar 2022
Assessing the relevance of lifestyle interventions for managing MS 1:45
Assessing the relevance of lifestyle interventions for managing MS
Agne Straukiene • 16 Mar 2022
Developing programs focusing on lifestyle interventions to manage MS 2:03
Developing programs focusing on lifestyle interventions to manage MS
Agne Straukiene • 16 Mar 2022
Elucidating the causes of MS with evidence-based studies 1:49
Elucidating the causes of MS with evidence-based studies
Agne Straukiene • 16 Mar 2022
Study of patients with RRMS treated with cladribine 4:17
Study of patients with RRMS treated with cladribine
Virginia Meca-Lallana • 28 Feb 2022
Ethnic study on access to healthcare in MS patients 0:51
Ethnic study on access to healthcare in MS patients
Mitzi Joi Williams • 25 Feb 2022
Addressing ethnic diversity in MS trials and research: a multipronged approach 1:50
Addressing ethnic diversity in MS trials and research: a multipronged approach
Mitzi Joi Williams • 25 Feb 2022
The content of VJNeurology is intended for healthcare professionals